India has the highest prevalence of diabetes globally, with an estimated 77 million people living with the condition and an expected 134 million cases by 2045
India-Sweden Healthcare Innovation Centre in collaboration with AIIMS Jodhpur and AstraZeneca India launches an e-learning Upskilling Program in Diabetes Management for nurses
First advanced hybrid closed-loop insulin pump system in India features automatic insulin delivery, automatic correction boluses, and bluetooth connectivity
The company claims that its Empagliflozin tablets are the most affordable in India
The consultations are virtual and they have launched the Diabetes Reversal Programme to address the issue
New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system
Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada
New home-use glucometer delivers results in under 10 seconds with simplified testing, large memory storage, and user-friendly design
Immediate opportunity in the $10.2 billion U.S. market as the diabetes therapy will be manufactured at Zydus’ SEZ Ahmedabad facility
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
Subscribe To Our Newsletter & Stay Updated
